MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/dar.70186

Медицинская библиотека · Drug and alcohol review · 2026

Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community-Recruited Study.

Piret Evelyne Marie, Palis Heather, Crabtree Alexis, Choi JinCheol, DeBeck Kora, Hayashi Kanna, Law Michael R, Milloy M-J

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Gabapentin is widely prescribed off-label to treat pain. However, there are concerns about the proliferation of medical and non-medical use, and the potential increased risk of overdose death associated with concurrent opioid use. Despite these considerations, prescription gabapentin use among people who use unregulated drugs is uncharacterised in Canada. Therefore, we investigated trends and factors associated with being prescribed gabapentin for pain among community-recruited people who use opioids.

METHODS

Data were derived from three prospective cohort studies of people who use unregulated drugs in Vancouver, Canada, restricted to periods of opioid use (i.e., unregulated use, non-medical use, and/or opioid agonist treatment). We characterised factors associated with reporting gabapentin for pain between 2014 and 2020 using multivariable generalised estimating equations. Trends in self-reported prescription (2014-2020) and non-medical (2016-2024) gabapentin use were explored.

RESULTS

Between 2014 and 2020, we included 10,999 observations from 2039 participants who had a baseline median age of 38 years and were 62.4% male and 57.5% White. Gabapentin prescriptions for pain were reported by 255 (12.5%) participants. Observations reporting a neuropathic pain diagnosis had 3.54 times the adjusted odds (95% CI 2.81, 4.46) of being prescribed gabapentin. From 2014 to 2020, the prevalence of gabapentin prescriptions rose from 5.4% to 7.8%. Non-medical gabapentin use remained low.

DISCUSSION AND

CONCLUSIONS

Among people who use opioids, we observed an increase in gabapentin prescriptions for pain between 2014 and 2020. Gabapentin prescriptions were strongly associated with reporting a neuropathic pain diagnosis. Rates of non-medical gabapentin use were substantially lower than rates reported internationally.

Для цитирования: Piret Evelyne Marie, Palis Heather, Crabtree Alexis, Choi JinCheol, DeBeck Kora, Hayashi Kanna, Law Michael R, Milloy M-J. Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community-Recruited Study.. Drug and alcohol review. 2026. DOI: 10.1111/dar.70186.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.